ZyVersa Therapeutics Financial Overview
ZyVersa Therapeutics's market cap is currently $1.08M. The company's EPS TTM is $-2.56; its P/E ratio is -0.03; ZyVersa Therapeutics is scheduled to report earnings on November 19, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
